Construction and validation of a prognostic marker and risk model for HCC ultrasound therapy combined with WGCNA identification

Background: Hepatocellular carcinoma (HCC) is a malignant tumor with a highly aggressive and metastatic nature. Ultrasound remains a routine monitoring tool for screening, treatment and post-treatment recheck of HCC. Therefore, it is of great significance to explore the role of ultrasound therapy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Yunlong, Jing, Yu, Guo, Lingling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573990/
https://www.ncbi.nlm.nih.gov/pubmed/36263426
http://dx.doi.org/10.3389/fgene.2022.1017551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573990/
https://www.ncbi.nlm.nih.gov/pubmed/36263426
http://dx.doi.org/10.3389/fgene.2022.1017551

Ejemplares similares